HERON THERAPEUTICS, INC. /DE/ Quarterly Operating Lease, Liability in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Heron Therapeutics, Inc. /De/ quarterly Operating Lease, Liability history and growth rate from Q4 2018 to Q2 2024.
  • Heron Therapeutics, Inc. /De/ Operating Lease, Liability for the quarter ending June 30, 2024 was $4.48M, a 33.5% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $4.48M -$2.26M -33.5% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $5.18M -$2.41M -31.8% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $5.88M -$2.32M -28.3% Dec 31, 2023 10-K 2024-03-12
Q3 2023 $6.54M -$2.24M -25.5% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $6.74M -$2.59M -27.8% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $7.59M -$2.28M -23.1% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $8.19M -$2.22M -21.3% Dec 31, 2022 10-K 2023-03-29
Q3 2022 $8.77M -$6.7M -43.3% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $9.33M -$6.85M -42.3% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $9.88M -$7M -41.5% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $10.4M -$7.15M -40.7% Dec 31, 2021 10-K 2022-02-28
Q3 2021 $15.5M -$2.74M -15.1% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $16.2M -$2.67M -14.2% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $16.9M -$2.59M -13.3% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $17.6M +$3.39M +23.9% Dec 31, 2020 10-K 2021-02-24
Q3 2020 $18.2M +$5.71M +45.6% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $18.8M +$5.87M +45.2% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $19.5M +$5.71M +41.5% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $14.2M -$332K -2.29% Dec 31, 2019 10-K 2020-03-02
Q3 2019 $12.5M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $13M Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $13.8M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $14.5M Jan 1, 2019 10-K 2020-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.